DACARBAZINE FOR INJECTION BP DIN 02241445
Health Canada record
| Active ingredient(s) | DACARBAZINE 600 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AX04 DACARBAZINE |
| Original market date | 04-Apr-2000 |
| Current status date | 31-May-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DACARBAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02566702 | DACARBAZINE FOR INJECTION | STERIMAX INC | Powder For Solution | DACARBAZINE 200 MG | Approved |
| 02566710 | DACARBAZINE FOR INJECTION | STERIMAX INC | Powder For Solution | DACARBAZINE 500 MG | Approved |
| 00521183 | DTIC DOME INJ 200MG/VIAL | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Liquid | DACARBAZINE 200 MG | Cancelled Post Market |
| 02154854 | DTIC-DOME -PWS IV 200MG/VIAL | BAYER INC | Powder For Solution | DACARBAZINE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19367 | 2017-05-31 | Abbreviated New Drug Submission (ANDS) | MERGER - BUYOUT |
| 8829 | 2007-06-12 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER NAME CHANGE |
| 415 | 2002-09-23 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER NAME CHANGE |
| 1127 | 2000-01-13 | Abbreviated New Drug Submission (ANDS) |
International API supply for DACARBAZINE
3 valid EDQM Certificates of Suitability from 3 holders. 3 active FDA Drug Master Files.
Request a quote for DACARBAZINE FOR INJECTION BP